Company intelligence / Profile preview

Gut Health

Vilnius, Vilnius county, Lithuania

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Gut Health, UAB markets clinically-formulated probiotic and fiber-based dietary supplements designed to restore and maintain gut microbiome balance. Their lead brands (Bioma Probiotics, ColonBroom GLP-1 Booster) combine multi-strain probiotics, prebiotics, enzymes, and select plant extracts for improved digestion, immunity, and metabolic health. No clinical trial data disclosed for interventions; products are marketed as consumer supplements with strong user and market growth.

Therapeutic areas: ImmunologyEndocrinologyPsychiatryGastroenterologyDermatologyWomen's Health
Modalities: Live biotherapeutic product therapyMicrobial therapyPrebioticsDigestive enzyme therapySmall molecule (plant extract, berberine)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Gut Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut Health.

Explore the full profile